Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
Abstract
This paper looks at the problem confronting a doctor evaluating a patient with anticentromere antibody who does not have evidence of disease along the spectrum from CREST (calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, telangiectasia) to progressive systemic sclerosis. Of 33 people with anticentromere antibody, 21 had CREST and two had scleroderma. Of the other 10 with a positive anticentromere antibody, three had systemic lupus erythematosus (two with digital vasculitis), three very active seronegative polyarthritis, three Raynaud's phenomenon, and one a claudication syndrome involving the legs. A positive antinuclear antibody test does not always indicate the presence of a connective tissue disease, but the presence of anticentromere antibody without systemic sclerosis or CREST often indicates the presence of another sometimes serious underlying rheumatic or connective tissue disease.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (547K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 1980 Jun;23(6):617–625. [PubMed] [Google Scholar]
- McCarty GA, Rice JR, Bembe ML, Barada FA., Jr Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum. 1983 Jan;26(1):1–7. [PubMed] [Google Scholar]
- Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL. The anticentromere antibody: disease specificity and clinical significance. Mayo Clin Proc. 1984 Oct;59(10):700–706. [PubMed] [Google Scholar]
- Chorzelski TP, Jablonska S, Beutner EH, Blaszczyk M, Jarzabek-Chorzelska M, Kencka D, Krasny S, Kumar V, Tchórzewska A. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis. Br J Dermatol. 1985 Oct;113(4):381–389. [PubMed] [Google Scholar]
- Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol. 1986 Oct;13(5):911–916. [PubMed] [Google Scholar]
- Miller MH, Littlejohn GO, Davidson A, Jones B, Topliss DJ. The clinical significance of the anticentromere antibody. Br J Rheumatol. 1987 Feb;26(1):17–21. [PubMed] [Google Scholar]
- Modena V, Marengo C, Amoroso A, Rosina F, Costantini P, Bellando P, Coppo R, Rizzetto M. Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. Clin Exp Rheumatol. 1986 Apr-Jun;4(2):129–134. [PubMed] [Google Scholar]
- Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol. 1985 Jul;38(7):801–805. [PMC free article] [PubMed] [Google Scholar]
- Ruffatti A, Peserico A, Glorioso S, Fiocco U, Rossi L, Gambari P, Todesco S. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol. 1986 Oct;15(4 Pt 1):637–642. [PubMed] [Google Scholar]
- Mitchell SR, McCarty GA, Katz P. Anticentromere antibody is not specific for connective tissue disease with a promising prognosis. Arthritis Rheum. 1985 Sep;28(9):1076–1077. [PubMed] [Google Scholar]
- McDougal JS, Redecha PB, Inman RD, Christian CL. Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest. 1979 Apr;63(4):627–636. [PMC free article] [PubMed] [Google Scholar]
- McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, et al. Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity for rheumatoid arthritis. Arthritis Rheum. 1982 Oct;25(10):1156–1166. [PubMed] [Google Scholar]
- Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. [PubMed] [Google Scholar]
- Migliaresi S, Picillo U, Terri G, Improta RD, La Palombara F, Giordano M. Infrequency of anticentromere antibody in patients without systemic sclerosis and without Raynaud's phenomenon. Arthritis Rheum. 1987 Mar;30(3):358–359. [PubMed] [Google Scholar]
- Goldman JA, Klimek GA, Ali R. Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum. 1976 Jul-Aug;19(4):669–676. [PubMed] [Google Scholar]
- Rothfield N, Whitaker D, Bordwell B, Weiner E, Senecal JL, Earnshaw W. Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum. 1987 Dec;30(12):1416–1419. [PubMed] [Google Scholar]
- Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol. 1985 Jul;36(1):120–128. [PubMed] [Google Scholar]